• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Rab8A promotes breast cancer progression by increasing surface expression of Tropomyosin-related kinase B" [Canc. Lett. 535 (2022) 215629].

作者信息

Liu Yansong, Zhang Zhonghua, Gao Xuefeng, Ma Qinghua, Yu Zhiyong, Huang Shuhong

机构信息

Department of Breast Disease, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.

Department of Breast Disease, Dongping County Hospital, Taian, Shandong, China.

出版信息

Cancer Lett. 2022 Jul 28;539:215701. doi: 10.1016/j.canlet.2022.215701. Epub 2022 May 6.

DOI:10.1016/j.canlet.2022.215701
PMID:35527117
Abstract
摘要

相似文献

1
Corrigendum to "Rab8A promotes breast cancer progression by increasing surface expression of Tropomyosin-related kinase B" [Canc. Lett. 535 (2022) 215629].《“Rab8A通过增加原肌球蛋白相关激酶B的表面表达促进乳腺癌进展”的更正》[《癌症快报》535 (2022) 215629]
Cancer Lett. 2022 Jul 28;539:215701. doi: 10.1016/j.canlet.2022.215701. Epub 2022 May 6.
2
Corrigendum to "SUMOylation of SYNJ2BP-COX16 promotes breast cancer progression through DRP1-mediated mitochondrial fission" [Canc. Lett. 547 (2022) 215871].
Cancer Lett. 2022 Nov 28;549:215923. doi: 10.1016/j.canlet.2022.215923. Epub 2022 Sep 24.
3
Corrigendum to "Voltage-gated sodium channel Nav1.5 promotes tumor progression and enhances chemosensitivity to 5-fluorouracil in colorectal cancer" [Canc. Lett. 500 (2021) 119-131].《电压门控钠通道Nav1.5促进肿瘤进展并增强结直肠癌对5-氟尿嘧啶的化疗敏感性》[《癌症快报》500 (2021) 119 - 131]的勘误
Cancer Lett. 2021 Sep 28;516:57-60. doi: 10.1016/j.canlet.2021.05.024. Epub 2021 Jun 3.
4
Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Canc. Lett. 337 (2013) 226-236].《“MicroRNA-21通过AKT/ERK途径抑制PTEN和hSulf-1表达并促进肝细胞癌进展”的勘误》[《癌症快报》337 (2013) 226 - 236]
Cancer Lett. 2020 Mar 31;473:198-199. doi: 10.1016/j.canlet.2019.12.034. Epub 2020 Jan 8.
5
Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-related manner" [Canc. Lett. 371 (2016) 354-365].《“长链非编码RNA LOC389641以TNFRSF10A相关方式通过调控E-钙黏蛋白促进胰腺导管腺癌进展并增加细胞侵袭能力”的勘误》[《癌症快报》371卷（2016年）第354 - 365页]
Cancer Lett. 2022 Oct 1;545:215859. doi: 10.1016/j.canlet.2022.215859. Epub 2022 Aug 6.
6
Corrigendum to "Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer" [Canc. Lett. 438 (2018, Dec 1) 165-173].《“靶向低密度脂蛋白受体相关蛋白8抑制三阴性乳腺癌中的乳腺癌干细胞”的勘误》[《癌症快报》438卷（2018年12月1日）165 - 173页]
Cancer Lett. 2020 Jun 28;480:51. doi: 10.1016/j.canlet.2020.01.013. Epub 2020 Mar 27.
7
Corrigendum to "AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma" [Canc. Lett. 414 (2018) 71-80].《AGBL2通过IRGM调节的自噬和增强的极光激酶A活性促进肝癌细胞生长》[《癌症通讯》414(2018)71 - 80]的勘误
Cancer Lett. 2022 Jul 28;539:215700. doi: 10.1016/j.canlet.2022.215700. Epub 2022 May 4.
8
Corrigendum to "Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer" [Canc. Lett. 459(2019)204-215].《巨噬细胞表达的CD51通过TGF-β1/smad2/3轴促进胰腺癌中的癌症干细胞特性》的勘误[《癌症快报》459(2019)204 - 215]
Cancer Lett. 2022 Nov 1;548:215897. doi: 10.1016/j.canlet.2022.215897. Epub 2022 Aug 30.
9
Corrigendum to "Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM." [Canc. Lett. 449 (2019) 31-44].《“多嘧啶序列结合蛋白1通过MEIS2和PKM的可变剪接促进膀胱癌的淋巴转移和增殖”的勘误》[《癌症通讯》449（2019）31 - 44]
Cancer Lett. 2021 Mar 1;500:292-293. doi: 10.1016/j.canlet.2020.12.027. Epub 2020 Dec 31.
10
Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233].《“DIO3，甲状腺激素失活酶，促进高级别浆液性卵巢癌的肿瘤发生和代谢重编程”的勘误》[《癌症通讯》501 224 - 233]
Cancer Lett. 2023 Jun 1;563:216196. doi: 10.1016/j.canlet.2023.216196. Epub 2023 Apr 25.